Abdominal Visceral Lesions in von Hippel‐Lindau Disease: Incidence and Clinical Behavior of Pancreatic and Adrenal Lesions at a Single Center von Delman, Keith A., Shapiro, Suzanne E., Jonasch, Eric W., Lee, Jeffrey E., Curley, Steven A., Evans, Douglas B., Perrier, Nancy D.

Volltext

Exposure-response modeling of cabozantinib in patients with renal cell carcinoma : Implications for patient care von Castellano, Daniel, Maroto Rey, Pablo, Benzaghou, Fawzi, Taguieva, Naila, Nguyen, Linh, Clary, Douglas O, Jonasch, Eric W, Universitat Autònoma de Barcelona

Volltext bestellen

Renal cell carcinoma von Jonasch, Eric, Gao, Jianjun, Rathmell, W Kimryn

Volltext

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality von Jonasch, Eric, Walker, Cheryl Lyn, Rathmell, W. Kimryn

Volltext

Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages von Obradovic, Aleksandar, Chowdhury, Nivedita, Haake, Scott M., Ager, Casey, Wang, Vinson, Vlahos, Lukas, Guo, Xinzheng V., Aggen, David H., Rathmell, W. Kimryn, Jonasch, Eric, Johnson, Joyce E., Roth, Marc, Beckermann, Kathryn E., Rini, Brian I., McKiernan, James, Califano, Andrea, Drake, Charles G.

Volltext

Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease von Jonasch, Eric, Donskov, Frede, Iliopoulos, Othon, Rathmell, W. Kimryn, Narayan, Vivek K, Maughan, Benjamin L, Oudard, Stephane, Else, Tobias, Maranchie, Jodi K, Welsh, Sarah J, Thamake, Sanjay , Park, Eric K, Perini, Rodolfo F, Linehan, W. Marston, Srinivasan, Ramaprasad

Volltext

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma von Liu, Xian-De, Kong, Wen, Peterson, Christine B., McGrail, Daniel J., Hoang, Anh, Zhang, Xuesong, Lam, Truong, Pilie, Patrick G., Zhu, Haifeng, Beckermann, Kathryn E., Haake, Scott M., Isgandrova, Sevinj, Martinez-Moczygemba, Margarita, Sahni, Nidhi, Tannir, Nizar M., Lin, Shiaw-Yih, Rathmell, W. Kimryn, Jonasch, Eric

Volltext

Dual Chromatin and Cytoskeletal Remodeling by SETD2 von Park, In Young, Powell, Reid T., Tripathi, Durga Nand, Dere, Ruhee, Ho, Thai H., Blasius, T. Lynne, Chiang, Yun-Chen, Davis, Ian J., Fahey, Catherine C., Hacker, Kathryn E., Verhey, Kristen J., Bedford, Mark T., Jonasch, Eric, Rathmell, W. Kimryn, Walker, Cheryl Lyn

Volltext

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC) von Rini, Brian I., Battle, Dena, Figlin, Robert A., George, Daniel J., Hammers, Hans, Hutson, Tom, Jonasch, Eric, Joseph, Richard W., McDermott, David F., Motzer, Robert J., Pal, Sumanta K., Pantuck, Allan J., Quinn, David I., Seery, Virginia, Voss, Martin H., Wood, Christopher G., Wood, Laura S., Atkins, Michael B.

Volltext

Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling von Cohen, Lorenzo, Cole, Steven W, Sood, Anil K, Prinsloo, Sarah, Kirschbaum, Clemens, Arevalo, Jesusa M G, Jennings, Nicholas B, Scott, Shellie, Vence, Luis, Wei, Qi, Kentor, Diane, Radvanyi, Laszlo, Tannir, Nizar, Jonasch, Eric, Tamboli, Pheroze, Pisters, Louis

Volltext

Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients von GRIFFIOEN, Arjan W, MANS, Laurie A, DE GRAAF, Annemarie M. A, NOWAK-SLIWINSKA, Patrycja, DE HOOG, Céline L. M. M, DE JONG, Trees A. M, VYTH-DREESE, Florry A, BEIJNUM, Judy R. Van, BEX, Axel, JONASCH, Eric

Volltext

VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma von Zhang, Jing, Wu, Tao, Simon, Jeremy, Takada, Mamoru, Saito, Ryoichi, Fan, Cheng, Liu, Xian-De, Jonasch, Eric, Xie, Ling, Chen, Xian, Yao, Xiaosai, Teh, Bin Tean, Tan, Patrick, Zheng, Xingnan, Li, Mingjie, Lawrence, Cortney, Fan, Jie, Geng, Jiang, Liu, Xijuan, Hu, Lianxin, Wang, Jun, Liao, Chengheng, Hong, Kai, Zurlo, Giada, Parker, Joel S, Auman, J Todd, Perou, Charles M, Rathmell, W Kimryn, Kim, William Y, Kirschner, Marc W, Kaelin, Jr, William G, Baldwin, Albert S, Zhang, Qing

Volltext

Recommendations for the Management of Rare Kidney Cancers von Giles, Rachel H., Choueiri, Toni K., Heng, Daniel Y., Albiges, Laurence, Hsieh, James J., Linehan, W. Marston, Pal, Sumanta, Maskens, Deborah, Paseman, Bill, Jonasch, Eric, Malouf, Gabriel, Molina, Ana M., Pickering, Lisa, Shuch, Brian, Srinivas, Sandy, Srinivasan, Ramaprasad, Tannir, Nizar M., Bex, Axel

Volltext

State of the science: an update on renal cell carcinoma von Jonasch, Eric, Futreal, P Andrew, Davis, Ian J, Bailey, Sean T, Kim, William Y, Brugarolas, James, Giaccia, Amato J, Kurban, Ghada, Pause, Armin, Frydman, Judith, Zurita, Amado J, Rini, Brian I, Sharma, Pam, Atkins, Michael B, Walker, Cheryl L, Rathmell, W Kimryn

Volltext

Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma von Jonasch, Eric, Slack, Rebecca S, Geynisman, Daniel M, Hasanov, Elshad, Milowsky, Matthew I, Rathmell, W Kimryn, Stovall, Summer, Juarez, Donna, Gilchrist, Troy R, Pruitt, Lisa, Ornstein, Moshe C, Plimack, Elizabeth R, Tannir, Nizar M, Rini, Brian I

Volltext

Tumor-Specific Isoform Switch of the Fibroblast Growth Factor Receptor 2 Underlies the Mesenchymal and Malignant Phenotypes of Clear Cell Renal Cell Carcinomas von QI ZHAO, CABALLERO, Otavia L, DAVIS, Ian D, JONASCH, Eric, TAMBOLI, Pheroze, YUNG, W. K. Alfred, WEINSTEIN, John N, SHAW, Kenna, STRAUSBERG, Robert L, JUN YAO

Volltext

An open-label phase II study to evaluate PT2977 for the treatment of von Hippel-Lindau disease-associated renal cell carcinoma von Jonasch, Eric, Park, Eric Kristopher, Thamake, Sanjay, Hirmand, Mohammad, Linehan, W. Marston, Srinivasan, Ramaprasad

Volltext

Effect of erythropoietin-stimulating agent use on belzutifan antitumor activity in patients with VHL disease–associated renal cell carcinoma: Post hoc analysis of the LITESPARK-004... von Maughan, Benjamin L., Srinivasan, Ramaprasad, Iliopoulos, Othon, Bundsbæk Bøndergaard Iversen, Ane, Narayan, Vivek, Oudard, Stephane, Else, Tobias, Maranchie, Jodi K., Beckermann, Katy, Fu, Wei, Perini, Rodolfo F., Liu, Yanfang, Linehan, W. Marston, Jonasch, Eric

Volltext

HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas von Sun, Mianen, Tong, Pan, Kong, Wen, Dong, Baijun, Huang, Yiran, Park, In Young, Zhou, Lijun, Liu, Xian-De, Ding, Zhiyong, Zhang, Xuesong, Bai, Shanshan, German, Peter, Powell, Reid, Wang, Quan, Tong, Xuefei, Tannir, Nizar M, Matin, Surena F, Rathmell, W Kimryn, Fuller, Gregory N, McCutcheon, Ian E, Walker, Cheryl L, Wang, Jing, Jonasch, Eric

Volltext

Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement von Bratslavsky, Gennady, Mendhiratta, Neil, Daneshvar, Michael, Brugarolas, James, Ball, Mark W., Metwalli, Adam, Nathanson, Katherine L., Pierorazio, Phillip M., Boris, Ronald S., Singer, Eric A., Carlo, Maria I., Daly, Mary B., Henske, Elizabeth P., Hyatt, Colette, Middleton, Lindsay, Morris, Gloria, Jeong, Anhyo, Narayan, Vivek, Rathmell, W. Kimryn, Vaishampayan, Ulka, Lee, Bruce H., Battle, Dena, Hall, Michael J., Hafez, Khaled, Jewett, Michael A. S., Karamboulas, Christina, Pal, Sumanta K., Hakimi, A. Ari, Kutikov, Alexander, Iliopoulos, Othon, Linehan, W. Marston, Jonasch, Eric, Srinivasan, Ramaprasad, Shuch, Brian

Volltext